Every Mental Health story tagged Conditions.
University of Birmingham scientists have demonstrated that blocking the P2X7 receptor significantly reduces inflammatory responses in living human brain tissue, offering a new therapeutic strategy for conditions like traumatic brain injury, Alzheimer's, Parkinson's, and depression.
A major study finds Medicaid beneficiaries with autism have a life expectancy of 64.9 years, nearly 14 years shorter than the general U.S.
Neuroscientists have pinpointed a small brain region, the amygdalostriatal transition zone (ASt), that maintains neural activity for the full duration of a threat cue.
A new study shows the proportion of older Americans at risk for major drug interactions fell from 25.7% to 22.3% between 2015-2016 and 2021-2023.
A large study finds amyloid-beta accumulation in cognitively healthy older adults predicts future brain shrinkage.
A study in JAMA Network Open found gabapentin dispensing to Michigan Medicaid patients rose immediately after the state removed it from its controlled substance schedule.
Semaglutide, the active ingredient in Ozempic and Wegovy, extended lifespan and improved markers of aging in healthy older mice.
Harvard biologists have identified molecular signals that allow different types of neurons to control how their wiring is insulated with myelin.
A Columbia University study finds women with prior gestational diabetes had a lower risk of developing type 2 diabetes if they lived in more walkable neighborhoods.
A national study published in August 2026 found that doctors often disagree on lung sounds when examining children for pneumonia.
Americans are traveling to countries like Greece for cheaper IVF treatments, as U.S. costs can exceed $29,000 per cycle, despite experts warning of risks.
President Trump has nominated Heidi Overton, a top White House aide, to lead the FDA. The nomination has sparked controversy, with some critics questioning her qualifications and stance on abortion and vaccination.
Researchers have made significant progress in understanding N-methyl-D-aspartate receptor (NMDAR) encephalitis, a condition characterized by widespread neuropsychiatric symptoms. A recent study has shed light on the structural brain changes and clinical outcomes of patients with NMDA receptor encephalitis in Germany.